Kyowa Kirin has a total of 3855 patents globally, out of which 1931 have been granted. Of these 3855 patents, more than 39% patents are active. The USA is where Kyowa Kirin has filed the maximum number of patents, followed by Japan and European Countries, it has generated an annual revenue of $3.14 billion in the year 2021. Parallelly, Japan seems to be the main focused R&D centre of Kyowa Kirin.
Kyowa Kirin was founded in the year 1949. It is one of the top 40 revenue-producing pharmaceutical and biotechnology companies in the world and is a subsidiary of Kirin Holdings. As of December 2022, Kyowa Kirin has a market cap of $12.13 Billion.
Do read about some of the most popular patents of Kyowa Kirin which have been covered by us in this article and also you can find Kyowa Kirin patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kyowa Kirin patent portfolio.
How many patents does Kyowa Kirin have?
Kyowa Kirin has a total of 3855 patents globally. These patents belong to 876 unique patent families. Out of 3855 patents, 1538 patents are active.
How Many Patents did Kyowa Kirin File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Kyowa Kirin Applications Filed | Kyowa Kirin Patents Granted |
| 2022 | 11 | 54 |
| 2021 | 52 | 101 |
| 2020 | 84 | 67 |
| 2019 | 116 | 70 |
| 2018 | 149 | 122 |
| 2017 | 156 | 156 |
| 2016 | 211 | 138 |
| 2015 | 151 | 134 |
| 2014 | 37 | 115 |
| 2013 | 183 | 128 |
| 2012 | 146 | 144 |
| 2011 | 205 | 132 |
Which Kyowa Kirin Drug Patents are Expiring in the Next 10 Years?
The patent no. US8318201B2 which is expiring in Sep, 2027, describing stabilizing a diarylvinylene compound or its salt in a solid form involves incorporating an inorganic substance and/or a colorant into the formulation. This process prevents undesired changes like isomerization or dimerization at the vinylene moiety of the compound.
Given below is the list of few drugs patented by Kyowa Kirin accompanied by a patent relevant to the drug which will be available for generic drug manufacturing and usage within the next/upcoming 10 years for treatment of various diseases and disorders.
| Drug Name | Patent Number | Patent Title | Patent Expiration |
| Nourianz | US8318201B2 | Method Of Stabilizing Diarylvinylene… | Sep, 2027 |
| Sancuso | US7608282B2 | Transdermal Granisetron | Jan, 2025 |
Interested in knowing about Kyowa Kirin’s Drug Patents Expiring in the next 10 years?
How many Kyowa Kirin patents are Alive/Dead?
How Many Patents did Kyowa Kirin File in Different Countries?
Countries in which Kyowa Kirin Filed Patents
| Country | Patents |
| United States Of America | 606 |
| Japan | 512 |
| Europe | 405 |
| Korea (South) | 264 |
| Canada | 208 |
| China | 195 |
| Germany | 193 |
| Australia | 187 |
| Taiwan | 124 |
| Hong Kong (S.A.R.) | 120 |
| Spain | 115 |
| Denmark | 59 |
| India | 44 |
| Austria | 41 |
| Singapore | 36 |
| Portugal | 36 |
| Brazil | 34 |
| Poland | 31 |
| Mexico | 27 |
| Norway | 26 |
| Israel | 23 |
| Hungary | 22 |
| Slovenia | 22 |
| New Zealand | 21 |
| Cyprus | 17 |
| South Africa | 17 |
| Croatia | 13 |
| Eurasia | 13 |
| Lithuania | 11 |
Where are Research Centres of Kyowa Kirin Patents Located?
10 Best Kyowa Kirin Patents
US20040132140A1 is the most popular patent in the Kyowa Kirin portfolio. It has received 2001 citations so far from companies like Genentech, Centocor, and Seattle Genetics.
Below is the list of 10 most cited patents of Kyowa Kirin:
| Publication Number | Citation Count |
| US20040132140A1 | 2001 |
| US6946292B2 | 836 |
| US7214775B2 | 470 |
| WO2011155607A1 | 297 |
| US8552156B2 | 279 |
| US20080241884A1 | 215 |
| RS61443B1 | 215 |
| US20040259150A1 | 171 |
| US6423716B1 | 137 |
| WO2010117057A1 | 120 |